Physician

John Whetten Pratt, MD

According to 2025 Medicare claims, John Pratt, MD (NPI: 1073737532) practices ophthalmology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is V. EUGENE KILMORE, JR., M.D., P.C. (NPI: 1063418721; TIN: 232175708) and primary practice location at 17055-4375.

Pratt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 3,359 HCPCS/CPT codes, and received $300,954 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 1,090 prescription claims across 350 beneficiaries totaling $261,473 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 17 records totaling $359. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$210K$420K2015 Medicare payment: $336,028 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $378,321 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $320,798 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $327,573 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $420,324 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $366,511 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $383,720 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $365,664 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $345,831 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $300,954 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158073,304$336,028
20167753,631$378,321
20177802,954$320,798
20187372,812$327,573
20197343,250$420,324
20206312,769$366,511
20216863,042$383,720
20227162,963$365,664
20237353,431$345,831
20247003,359$300,954

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$160K$319K2015 Drug cost: $240,144 (USD; Tot_Drug_Cst)2016 Drug cost: $267,827 (USD; Tot_Drug_Cst)2017 Drug cost: $296,783 (USD; Tot_Drug_Cst)2018 Drug cost: $319,348 (USD; Tot_Drug_Cst)2019 Drug cost: $286,840 (USD; Tot_Drug_Cst)2020 Drug cost: $268,907 (USD; Tot_Drug_Cst)2021 Drug cost: $284,781 (USD; Tot_Drug_Cst)2022 Drug cost: $278,252 (USD; Tot_Drug_Cst)2023 Drug cost: $262,084 (USD; Tot_Drug_Cst)2024 Drug cost: $261,473 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153741,428$240,144
20164131,547$267,827
20173991,676$296,783
20184311,723$319,348
20193261,272$286,840
20203021,101$268,907
20213841,109$284,781
20223581,070$278,252
20233531,029$262,084
20243501,090$261,473

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens186299$333
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more189189$100
92014Established patient complete exam of visual system267271$73
92134Imaging of retina199247$26
92136Measurement of corneal curvature and depth of eye236447$21

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine482,490$50,414
LumiganBimatoprost885,519$44,772
CyclosporineCyclosporine352,310$23,109
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol694,934$20,225
XiidraLifitegrast15810$17,186

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$359ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Whetten Pratt, MD?

Tedicare shows public-source Medicare data for John Whetten Pratt, MD (NPI 1073737532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Whetten Pratt, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Whetten Pratt, MD?

John Whetten Pratt, MD is linked to V. EUGENE KILMORE, JR., M.D., P.C. (billing NPI 1063418721) in the available physician profile data.

Does John Whetten Pratt, MD have Open Payments data?

John Whetten Pratt, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.